Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 13, 2025 12:57 ET | Source: CMI

Online Mental Health Counseling Market worth USD 8,763.1 Million by 2032 - Exclusive Report by Coherent Market Insights

Burlingame, CA, June 13, 2025 (GLOBE NEWSWIRE) -- The Global Online Mental Health Counseling Market is estimated to be valued at USD 4,462.6 Mn in 2025 and is expected to reach USD 8,763.1 Mn by...
June 13, 2025 08:30 ET | Source: Rose Hill Health Holdings LLC

Rose Hill Apothecary Executes First Major International Export Deal, Supplying Research-Grade Psilocybin to Brazil

RUNAWAY BAY, Jamaica, June 13, 2025 (GLOBE NEWSWIRE) -- Rose Hill Apothecary (“The Company” or “Rose Hill”), a global leader in the research and intellectual property of premium psilocybin products,...
June 13, 2025 01:00 ET | Source: Avextra Pharma GmbH

Avextra Cannabis extract can potentially reduce symptom burden for late palliative patients

New Study Demonstrates Significant Symptom Relief for Late-Stage Palliative Patients Treated with Cannabis-based Medicines Bensheim, Germany – 13th June 2025 – According to the World Health...
June 12, 2025 10:07 ET | Source: Spark Biomedical

Spark Biomedical Completes Enrollment in a Neurostimulation Pivotal Trial for Opioid Use Disorder

Dallas, TX, June 12, 2025 (GLOBE NEWSWIRE) -- Spark Biomedical, a leader in wearable neurostimulation technology, has completed enrollment for its pivotal clinical trial, which aims to improve...
June 12, 2025 09:25 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics

Vancouver, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- Clearmind Medicine Engages Leading Government and Political Affairs Firm to Advance Psychedelic Therapeutics Clearmind Medicine Inc. (Nasdaq:...
June 12, 2025 01:00 ET | Source: Biogen Inc.

Dapirolizumab Pegol Phase 3 Data in SLE Presented at the Annual European Congress of Rheumatology (EULAR) Show Improvement in Fatigue and Reduction in Disease Activity

Dapirolizumab pegol (DZP) showed efficacy across multiple clinical endpoints in the PHOENYCS GO study, including fatigue and measures of disease activityDZP showed consistent improvements in fatigue,...
June 11, 2025 02:30 ET | Source: Angelini Ventures

Angelini Ventures Invests into €11.25 Million Seed Round for Elkedonia to Advance Neuroplastogens as Novel Therapeutics for Depression and Neuropsychiatric Disorders

Investment supports the development of first-in-class, non-addictive, non-hallucinogenic molecules with a non-synaptic target, differentiated from existing drugs First start-up company from Argobio’s...
June 11, 2025 02:30 ET | Source: Elkedonia

Elkedonia closes EUR 11 million seed round to advance neuroplastogens as novel therapeutics for depression and neuropsychiatric disorders

Proceeds to advance potentially disruptive, fast-acting therapeutics for treatment-resistant depression and other neuropsychiatric disordersFirst-in-class, non-addictive, non-hallucinogenic molecules...
June 11, 2025 02:30 ET | Source: Elkedonia

Elkedonia clôture un tour d’amorçage de 11 millions d’euros pour le développement de neuroplastogènes comme traitements novateurs contre la dépression et les troubles neuropsychiatriques

Les fonds permettront d’avancer dans la découverte de traitements potentiellement disruptifs, à action rapide, pour la dépression résistante aux traitements et d'autres troubles...
June 10, 2025 13:00 ET | Source: Sammivik Media Group

Sammivik Media Group, Led by Founder Mona Koch Madsen, Launches Animated Series to Address Chronic Health Issues in Greenland

Nuuk, Sermersooq , June 10, 2025 (GLOBE NEWSWIRE) -- Sammivik Media Group, a creative health communication agency based in Nuuk, Greenland, is launching a new animated video series focused on...